Bristol Myers expands footprint in India with drug development and IT center
Pharma giant Bristol Myers Squibb will expand its footprint in Hyderabad, India, with a life sciences hub that will focus on IT and drug development. It’s expected to be operational by the middle of 2023.
The company will invest about $100 million into the center and will employ around 1,500 people, according to local news sites. The exact location of the center in the region is unknown.
“We anticipate that the full development of this site will take place over the next few years,” a BMS spokesperson told Endpoints News. “We are still in the early phases of planning but are confident this expansion will further position BMS’s efforts to accelerate drug development, bolster internal digital innovation capacity and advance our commitment to being a more global company.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.